Gadoterate Meglumine

CHEBI:CHEBI_747723

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

package_marketing_start_date
21-DEC-22
pharm_class
Gadolinium-based Contrast Agent [EPC]
manufacturer_name
GE Healthcare
active_ingredient_strength
376.9 mg/mL
active_ingredient_name
GADOTERATE MEGLUMINE
package_description
5 SYRINGE in 1 PACKAGE (67684-2000-7) / 20 mL in 1 SYRINGE
unii
L0ND3981AG
spl_set_id
6f8c9fac-c995-4bf4-950d-ab89deb291b5
upc
0367684200127
package_ndc
67684-2000-5
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
listing_expiration_date
20241231
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
marketing_start_date
20130426
labeler_name
SIONC PHARMACEUTICALS PVT LTD
generic_name
Gadoterate meglumine
brand_name
CLARISCAN
brand_name_base
CLARISCAN
product_ndc
67684-2000
spl_id
c59dab89-460e-40d5-bf9c-9c548c3bb6df
application_number
ANDA218073